Serum uric acid (SUA) concentration is independently associated with blood pressure (BP) in adults. We examined this association in young adults at an age where anti-hypertension treatment, other potential confounding factors and co-morbidity are unlikely to occur. We assessed BP, anthropometric variables including weight, height, waist circumference (WC), body fat percent (using bioimpedance), lifestyle behaviors, SUA and blood lipids in 549 participants aged 19-20 years from a population-based cohort study (Seychelles Child Development Study). Mean (s.d.) SUA was higher in males than females, 0.33 (0.08) and 0.24 (0.07) mmol l À1 , respectively. Body mass index (BMI) was higher in females than males but BP was markedly higher in males than in females. SUA was associated with both systolic and diastolic BP. However, the magnitude of the linear regression coefficients relating BP and SUA decreased by up to 50% upon adjustment for BMI, WC or body fat percent. The association between SUA and BP was not altered upon further adjustment for alcohol intake, smoking, triglycerides or renal function. In fully adjusted models, SUA remained associated with BP (Po0.05) in females. In conclusion, adiposity substantially decreased the association between SUA and BP in young adults, and BP was independently associated with SUA in females. These findings suggest a role of adiposity in the link between hyperuricemia and hypertension.
Introduction
A positive association between serum uric acid (SUA) and blood pressure (BP) has consistently been found in adults. [1] [2] [3] [4] [5] [6] The strength of this association seems to be stronger in younger age groups 7 and tends to wane with increasing age and duration of hypertension. 8 Feig and Johnson 9 have suggested that SUA is involved in the early pathogenesis of primary hypertension. A link between SUA and BP might be related to endothelial dysfunction and activation of the renin-angiotensin system with subsequent uric acid-induced renal vasoconstriction. 10, 11 Recently, SUA was shown to be associated with coronary artery calcification, implicating a role in the pathogeneses of subclinical atherosclerosis. 12 In adults, hyperuricemia often co-exists with several cardiovascular risk factors including the metabolic syndrome and its individual components. 5, 13, 14 It has been suggested that insulin resistance determines SUA levels in patients with metabolic syndrome. 15 Furthermore, it has been suggested that hyperinsulinemia is the main link between abdominal obesity and high BP. 16 Hence, although SUA is associated with BP in adults, the association may not be entirely independent of the confounding effects of metabolic abnormalities, and may actually reflect a complex interplay of the individual components of the metabolic syndrome.
The prevalence of hypertension in children and adolescents is increasing worldwide [17] [18] [19] and elevated BP in children predicts the development of hypertension in adulthood. 20 Hence, it is important to understand the factors that can lead to hypertension at this young age for early detection and prevention purposes. It is interesting to examine the association between SUA and BP in young adults because of the limited concurrent effects of anti-hypertensive treatment, other potential confounding factors and co-morbidity at this young age. The purpose of this study was to examine the relationship between SUA and BP in young adults and to assess whether different markers of adiposity could modify this association.
Methods

Study population
The Republic of Seychelles is a small island nation in the Indian Ocean located east of Kenya. The majority of the population is of African descent. The crude national gross domestic product per capita grew from US$ 600 in 1976 to US$ 9000 in 2009, as a result of booming tourism and fishing industries and a growing service-oriented economy.
Between February 1989 and February 1990, a cohort of 779 children at the age of 6 months were enrolled as part of the Seychelles Child Development Study. Details of this cohort study have been previously described. 21 Informed consent was obtained from the subject and caregiver of every participant. The protocol was approved by human subjects review boards at both the University of Rochester, USA, and the Ministry of Health, Victoria, Seychelles. The subjects are being followed with the main objectives of studying child development and the association between prenatal exposure to mercury and fish consumption. The participants were aged 19-20 years at the time of this study.
Study procedures and measurement
In this study, we used cross-sectional data from the most recent follow-up visit in [2008] [2009] . A face-toface interviewer-based structured questionnaire was administered to assess lifestyle behaviors. Alcohol consumption was assessed on the basis of the number of days that an individual had had one or more drinks in the previous month and categories included none, 1-2 days and 3 days and above. Smoking was assessed on the basis of the number of days in the previous month on which a person had smoked at least one cigarette and categories included none, some days and every day. Weight was measured using a precision electronic scale (Seca 870, Seca, Hamburg, Germany), and height was measured with a fixed stadiometer (Seca 208). These instruments were regularly checked for accuracy. Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Body fat percent was assessed using a noninvasive bioimpedance analyzer (Omron Model HBF-306C, Omron Healthcare Europe BV, Hoofddorp, The Netherlands). BP was measured using a validated oscillometric automated device (Omron M5) 22 in the sitting position on the left arm and using an appropriately-sized cuff after a 5-min rest between 0800 and 1000 hours. Systolic BP (SBP) and diastolic BP (DBP) were based on the average of three readings. Venous blood samples were collected after an overnight fasting. SUA, triglycerides and creatine were measured in the central laboratory of Victoria hospital (Seychelles) using standard enzymatic methods (Konelab T series reagents, Thermofisher Scientific Oy, Vantaa, Finland) with a Thermo Konelab 30 automatic analyzer (Konelab Corp., Espoo, Finland). We estimated the glomerular filtration rate using the Cockcroft-Gault formula: [((140Àage (years)) Â weight (kg))/(serum creatinine (mmol l À1 ))] Â F, where F ¼ 1.23 for men and 1.04 for women.
Statistical analysis
We conducted analyses separately in males and females because of the largely different distribution of several variables, according to sex, including adiposity, BP and SUA. Correlation between SUA and covariates was examined using the non-parametric Spearman's rank test. We examined the association between SUA and SBP/DBP using multivariable linear regression. We have shown here standardized regression coefficients that express a change in the outcome (for example, mm Hg for SBP/DBP) corresponding to a 1 s.d. increase in SUA. In the adjusted models, we controlled for BMI, waist circumference (WC), body fat percent, alcohol, smoking, triglycerides and glomerular filtration rate. We used two-sided tests and considered statistical significance for Po0.05. Analyses were performed using Stata 11.0 (StataCorp., College Station, TX, USA).
Results
Of the 779 participants recruited in the initial cohort in 1989-1990, 21 549 participated in the follow-up visit in 2008-2009 and were included in the present analysis. Among them, the proportion of missing data ranged from 1% for WC to 12% for triglycerides. Table 1 summarizes the characteristics of the participants separately in males (46%) and females (54%) as well as in combination. SUA was higher in males (0.3±0.1 mmol l À1 ) than in females (0.2± 0.1 mmol l À1 ). Whereas males had a much higher mean SBP (121.4 ± 11.5 vs 110.4 ± 9.6 mm Hg), females had a higher mean DBP compared with males (69.1± 7.9 vs 66.8±8.3 mm Hg, Po0.001). Males reported higher alcohol consumption than females. Females had higher mean BMI (22.9 ± 5.6 vs 21.5 ± 3.7 kg m À2 , Po0.001) and body fat percent (27.3±8.0 vs 16.9± 6.6, Po0.001) than males. None of the participants were on anti-hypertensive medication.
The correlation of SUA with the different covariates is shown in Table 2 separately for males and females. SUA was strongly associated with SBP and DBP in females (r ¼ 0.20, P ¼ 0.001) but in males the correlation was statistically significant only with DBP (r ¼ 0.15, P ¼ 0.023). SUA was strongly associated with WC, BMI and body fat percent in both males and females (Po0.001). SUA was associated with triglycerides in both males and females (r ¼ 0.16, P ¼ 0.020 and r ¼ 0.19, P ¼ 0.003, respectively).
In multivariable analysis (Table 3) , SUA was positively associated with both SBP (beta standardized coefficients ¼ 0.16, P ¼ 0.001) and DBP (beta standardized coefficients ¼ 0.21, Po0.001) when adjusting for sex only. However, the relation between SUA and BP was attenuated by up to 50% upon further adjustment for BMI, WC or body fat percent, and the association with SBP became no longer significant in some instances. The relationship between SUA and BP remained virtually unchanged upon further adjustment for alcohol intake, smoking habits, serum triglyceride level and glomerular filtration rate. Although the effect of adiposity markers tended to be larger in females than in males, there was no statistically significant interaction by sex in the overall model.
Discussion
We found that the relationship between SUA and BP in young adults in Seychelles was strongly attenuated upon adjustment for adiposity markers but not for the other considered covariates. The association between SUA and BP tended to be stronger in females than in males, particularly for SBP, but we did not find an interaction of sex with SUA. These findings emphasize the role of adiposity as an intermediate variable linking SUA to BP.
The fact that we did not observe an effect modification by adiposity markers suggests that adiposity markers are either confounding the association between SUA and BP or in the causal pathway. Masuo et al. 4 showed that SUA predicts weight gain in humans and experimental animal studies have shown that allopurinol (a SUA-lowering drug) prevents both fructose-induced hyperuricaemia and weight gain. 23 Based on these results, it is difficult to differentiate whether hyperuricemia directly causes obesity or both hyperuricemia and obesity share a common cause, that is, increased fructose intake. Thus, it could be that obesity is in the causal pathway between SUA and BP and controlling for adiposity would explain the attenuation seen in the effect sizes.
Our finding of an association between SUA and BP is consistent with numerous studies showing that hyperuricemia independently predicts hypertension. [1] [2] [3] [4] [5] [6] An independent SUA-BP association is further substantiated by the finding that BP was lowered upon treatment with allopurinol in a randomized controlled trial in adolescents. 24 Johnson et al. 25 refer to two main mechanisms to Serum uric acid, blood pressure and adiposity T Lyngdoh et al account for a link between SUA and BP. First, uric acid inhibits nitric oxide synthase, which alters the endothelial function. This results in vasoconstriction of preglomerular arterioles in the kidney and an increase in systemic BP. 11, 26, 27 This SUA-related increase in BP seems to be independent of sodium intake, at least initially, and is sensitive to treatment with allopurinol. 28 Second, SUA may directly stimulate the renin-angiotensin system, which results in an increase in the expression of angiotensinogen and angiotensin II, subsequently leading to increased tubular reabsorption of sodium and uric acid. 29 Recently, SUA was observed to be associated with systemic inflammation, implicating the role of SUA in the pathogenesis of cardiovascular disease risks via inflammation. 30 The present study showed that SUA tended to be more strongly associated with DBP than SBP in males, whereas the strength of the SUA-BP association was fairly similar in females. Few studies are available in children, and one of them showed an association between SUA and both SBP and DBP, albeit only in males. 31 In another study, SUA was significantly associated with DBP but not with SBP, in children aged 6-18 years. 32 In the Bogalusa Heart Study, SUA in childhood was associated with both SBP and DBP during follow-up, and an increase in SUA from childhood to adulthood was a significant predictor of adult BP even upon adjustment of BMI. 1 Few studies have looked at the relationship between SUA and BP in Africa. BP was found to increase across SUA tertiles in black women in South Africa, 33 and these investigators also showed an independent relation between SUA and vascular resistance in men. Our finding of an association between SUA and BP in young adults in Seychelles concurs with the findings in adults: a positive relationship between SUA levels and BP was found in most studies, 2, 3, 5, 6 although not in all. 34, 35 It is important that this association be corroborated in children and young adults because studies in older adults are prone to confounding by many factors such as treatment, co-morbidity, reverse causation and so on.
In our study, the association between SUA and BP seemed to be stronger in females than in males although we could not identify a significant interaction by sex. Other studies have also found a stronger association between SUA and BP in females than in males. 36, 37 Furthermore, a recent metaanalysis showed hyperuricemia to increase coronary heart disease mortality in women but not in men. 38 There is no agreement in the literature about the reasons for a sex difference in these relationships. Consistent with our findings, it is well demonstrated that males have higher SUA levels than females, 39 whereas females have higher BP than males, particularly at a young age. 40 It has been suggested that the sex difference in SUA is related to the uricosuric effect of estrogen 41 and that sex hormones have a role in the relationship between SUA and hypertension. 42 In the present study, a possible explanation for the observed sex differences could be the greater adiposity in females than in males, which is consistent with our observation that adjustment for adiposity led to higher attenuation of the effect sizes of SUA on BP in the former than in the latter. Our findings are consistent with the frequently postulated claim that abdominal fat, which is particularly active metabolically, 43 might be a key factor in sex differences, as both WC and BMI are strongly correlated with abdominal fat. 44 It has also been suggested that leptin (a cytokine produced by fat adipcytes) may provide a link between adiposity and SUA. 45 Leptin levels are higher in individuals with high SUA, 46 as well as in females. 47, 48 Furthermore, women seem to show resistance to the lipostatic action of leptin, 47 suggesting that leptin may, in part, explain some of the sex differences. Studies that explore adiposity, SUA and BP in relation to leptin are needed.
We found that the association between SUA and BP was markedly attenuated when controlling for Adjusted for BMI, waist circumference, body fat percent, alcohol, smoking, triglycerides and GFR.
Serum uric acid, blood pressure and adiposity T Lyngdoh et al adiposity. This is consistent with previous studies: Zhang et al. 37 observed that the association between hyperuricemia and hypertension was partly mediated by WC and Bonora et al. 49 found a marked attenuation in the correlations between uric acid and Cardiovascular disease risk factors upon adjustment for BMI. Although the direction of causality between SUA and adiposity is unclear, it is well known that SUA is highly correlated with obesity and other metabolic abnormalities, including insulin resistance. 5, 13, 14, 50 It has been suggested that hyperuricemia inhibits nitric oxide availability and decreases insulin-mediated glucose uptake in skeletal muscle and may, therefore, have a role in the development of the metabolic syndrome. 51, 52 Other studies have suggested that hyperinsulinemia, a consequence of the metabolic syndrome, enhances the tubular reabsorption of uric acid and that this occurs concurrently with a decrease in sodium and potassium excretion, leading to elevated BP. 53 In both instances, the association between abdominal obesity and high BP is mediated by hyperinsulinemia, 16 which is consistent with the notion of a common exposure to hyperinsulinemia (and obesity) in the relation between SUA and BP. The cross-sectional nature of our study and our lack of information on serum insulin concentration do not allow us to corroborate the mechanisms involved. Whereas some studies suggest that cardiometabolic outcomes are associated more strongly with WC than with BMI in children, 54 we found similar effects of both BMI and WC on the relationship between SUA and BP, consistent with other studies. 55 Recently, it was hypothesized that the epidemic of metabolic syndrome, hyperuricemia and hypertension was partly due to increased consumption of fructose during the past few decades (for which soft drinks and fruit juices are the main sources). [56] [57] [58] Fructose is metabolized in the liver and breaks down into purine nucleotide. 57 It is the only sugar known to increase SUA levels. 59 Oral or intravenous administration of fructose rapidly increases SUA in humans. 59, 60 Furthermore, substantial evidence supports a relationship between fructose intake and hypertension through reduced sodium excretion 61 or increased sympathetic nervous system activity. 62 Our study lacked detailed data on soft drink consumption to assess this effect.
The relation between SUA and BP was not altered upon adjustment for serum triglycerides when taking adiposity markers into account (but the unadjusted association between triglycerides and SUA was significant in both males and females). This is unexpected as serum triglyceride concentration is correlated with both SUA 63 and hypertension, 64 which was also found in our study. However, except for one study that found an additive effect of triglycerides and SUA on DBP, 65 we could not find other studies that examined this question. It may be that the association between triglycerides and SUA, if present, is weaker among young persons. Furthermore, the limited statistical power due to our fairly small sample size did not allow us to detect small effects, if present. Likewise, we observed that other potential factors related to both SUA and BP, such as alcohol and renal function, did not alter the relation between SUA and BP.
Our study has several strengths, including the population-based design, the narrow age range of the participants, and the minimal presence of potential confounders and co-morbid conditions. However, we lacked information on insulin, leptin and fructose, which may be important factors involved in the relationship between SUA and BP. Furthermore, although the Seychelles Child Development Study is a cohort study, cardiometabolic outcomes (SUA, BP, lipids, renal function and so on) were available only for the 19-year evaluation so that the relation between SUA and BP in this study could only be analyzed using a cross-sectional design.
We found that SUA was associated with BP in young adults in the Seychelles, but this association was largely dependent on adiposity markers. This suggests a role of adiposity in the link between hyperuricemia and hypertension. If confirmed in other studies, our findings would underline another pathway linking adiposity and high BP, and further stress the importance of addressing the problem of adiposity early in life to prevent hyperuricemia and hypertension. However, more evidence is needed, including further randomized clinical trials. Furthermore, the mechanisms underlying the sexual dimorphism of the relationship between SUA and hypertension also needs further study, taking into account peripheral metabolic signals such as insulin and leptin.
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